Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes

PURPOSE: To report the visual acuity (VA) and foveal thickness (FT) changes after intravitreal bevacizumab for diabetic macular edema (DME) in previously vitrectomized eyes

Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema

Purpose: To report the long-term visual results and anatomical outcome as assessed by optical coherence tomography (OCT) after pars plana vitrectomy (PPV) with removal of the internal limiting membrane (ILM) in diabetic macular edema (DME)

Transconjonctival Sutureless Pars Plana Vitrectomy

Purpose: To evaluate the effectiveness, feasibility and safety of the transconjunctival sutureless vitrectomy (TSV) system for a variety of vitreoretinal procedures

Heavy Silicone Oil Tamponade for Complicated Retinal Detachment

Purpose: To report the early postoperative outcomes of perfluorohexyloctane/ silicone oil solution (Densiron-68) as an ocular endotamponade in the management of complicated retinal detachments involving the inferior quadrants

Pars Plana Vitrectomy and Intravitreal Phacoemulsification for Dislocated Crystalline Lens during Cataract Surgery

Purpose: To evaluate the effectiveness, timing and safety of intravitreal phacoemulsification with pars plana vitrectomy (PPV) in patients with posteriorly dislocated crystalline lens during cataract surgery

Pars Plana Vitrectomy for Pseudophakic Retinal Detachment with Unseen Retinal Breaks

Purpose: To evaluate the safety and efficacy of pars plana vitrectomy (PPV) for pseudophakic retinal detachment with unseen retinal breaks

Arteriovenous Adventitial Sheathotomy for Macular Branch Retinal Vein Occlusion

Purpose: To report the clinical course of a patient with macular branch retinal vein occlusion (MBRVO) who underwent pars plana vitrectomy (PPV) with internal limiting membrane (ILM) removal and arteriovenous (AV) adventitial sheathotomy

Primary 23-gauge vitreoretinal surgery for rhegmatogenous retinal detachment

AIM: To report the effectiveness and safety of primary 23-Gauge (G) vitreoretinal surgery for rhegmatogenous retinal detachment (RRD)